[1] KRISTYNA áOVá Emil R Lucie Rozkydalová. Anthelmintic Flubendazole and Its Potential Use in Anticancer Therapy.[J]. Acta medica (Hradec Kralove), 2017, 60 1: 5-11. DOI:
10.14712/18059694.2017.44[2] J MAKI T Y. A comparison of the effects of flubendazole and thiabendazole on the larvae of Angiostrongylus cantonensis, Trichinella spiralis, Diphyllobothrium erinacei and Hymenolepis nana in mice.[J]. Parasitology, 1983, 87 (Pt 3): 525-531. DOI:
10.1017/s0031182000083049[3] LACEY E. Mode of action of benzimidazoles[J]. Parasitology today (Personal ed.), 1990, 6 4: Pages 112-115. DOI:
10.1016/0169-4758(90)90227-u[4] ZHI-JIE HOU. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.[J]. Oncotarget, 2015, 6 8: 6326-6340. DOI:
10.18632/oncotarget.3436[5]
Tahlan, S., Singh, S., Kaira, M., Dey, H., Pandey, K. C. (2025). Benzimidazole‐Based Anthelmintic Drugs: Synthetic Strategy, Pharmacological Insights, and SAR Analysis. ChemistrySelect, 10(10).
https://doi.org/10.1002/slct.202405873